| Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial M Weller, N Butowski, DD Tran, LD Recht, M Lim, H Hirte, L Ashby, ... The Lancet Oncology 18 (10), 1373-1385, 2017 | 942 | 2017 |
| Safety and efficacy of bevacizumab with hypofractionated stereotactic irradiation for recurrent malignant gliomas PH Gutin, FM Iwamoto, K Beal, NA Mohile, S Karimi, BL Hou, S Lymberis, ... International Journal of Radiation Oncology* Biology* Physics 75 (1), 156-163, 2009 | 427 | 2009 |
| Treatment for brain metastases: ASCO-SNO-ASTRO guideline MA Vogelbaum, PD Brown, H Messersmith, PK Brastianos, S Burri, ... Neuro-oncology 24 (3), 331-357, 2022 | 322 | 2022 |
| Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial IR Kleckner, C Kamen, JS Gewandter, NA Mohile, CE Heckler, ... Supportive Care in Cancer 26, 1019-1028, 2018 | 299 | 2018 |
| Patterns and timing of recurrence after temozolomide-based chemoradiation for glioblastoma MT Milano, P Okunieff, RS Donatello, NA Mohile, J Sul, KA Walter, ... International Journal of Radiation Oncology* Biology* Physics 78 (4), 1147-1155, 2010 | 165 | 2010 |
| Primary spinal cord glioma: a Surveillance, Epidemiology, and End Results database study MT Milano, MD Johnson, J Sul, NA Mohile, DN Korones, P Okunieff, ... Journal of neuro-oncology 98, 83-92, 2010 | 157 | 2010 |
| The utility of body FDG PET in staging primary central nervous system lymphoma NA Mohile, LM DeAngelis, LE Abrey Neuro-oncology 10 (2), 223-228, 2008 | 156 | 2008 |
| Primary central nervous system lymphoma NA Mohile, LE Abrey Neurologic clinics 25 (4), 1193-1207, 2007 | 141 | 2007 |
| A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913 P Chinnaiyan, M Won, PY Wen, AM Rojiani, M Werner-Wasik, HA Shih, ... Neuro-oncology 20 (5), 666-673, 2018 | 127 | 2018 |
| Therapy for diffuse astrocytic and oligodendroglial tumors in adults: ASCO-SNO guideline NA Mohile, H Messersmith, NTN Gatson, AF Hottinger, AB Lassman, ... Neuro-oncology 24 (3), 358-383, 2022 | 94 | 2022 |
| Urgent considerations for the neuro-oncologic treatment of patients with gliomas during the COVID-19 pandemic NA Mohile, JO Blakeley, NTN Gatson, AF Hottinger, AB Lassman, DE Ney, ... Neuro-oncology 22 (7), 912-917, 2020 | 91 | 2020 |
| Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma PY Wen, A Omuro, MS Ahluwalia, HM Fathallah-Shaykh, N Mohile, ... Neuro-oncology 17 (9), 1275-1283, 2015 | 75 | 2015 |
| Treatment patterns, survival, and healthcare costs of patients with malignant gliomas in a large US commercially insured population S Ray, MM Bonafede, NA Mohile American health & drug benefits 7 (3), 140, 2014 | 68 | 2014 |
| A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study HI Robins, P Zhang, MR Gilbert, A Chakravarti, JF de Groot, SA Grimm, ... Journal of neuro-oncology 126, 309-316, 2016 | 64 | 2016 |
| Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study JS Gewandter, J Chaudari, C Ibegbu, R Kitt, J Serventi, J Burke, ... Supportive care in cancer 27, 1765-1774, 2019 | 48 | 2019 |
| Chemotherapy-induced peripheral neuropathy clinical trials: review and recommendations JS Gewandter, R Freeman, RA Kitt, G Cavaletti, LR Gauthier, ... Neurology 89 (8), 859-869, 2017 | 45 | 2017 |
| A state-of-the-art review and guidelines for tumor treating fields treatment planning and patient follow-up in glioblastoma J Trusheim, E Dunbar, J Battiste, F Iwamoto, N Mohile, D Damek, DA Bota, ... CNS oncology 6 (1), 29-43, 2017 | 45 | 2017 |
| Advances in primary central nervous system lymphoma LB Patrick, NA Mohile Current Oncology Reports 17, 1-8, 2015 | 43 | 2015 |
| Considerations in prophylaxis for tumor-associated epilepsy: prevention of status epilepticus and tolerability of newer generation AEDs T Wychowski, H Wang, L Buniak, JC Henry, N Mohile Clinical neurology and neurosurgery 115 (11), 2365-2369, 2013 | 43 | 2013 |
| Utility of brain FDG-PET in primary CNS lymphoma. NA Mohile, LM Deangelis, LE Abrey Clinical Advances in Hematology & Oncology: H&O 6 (11), 818-20, 840, 2008 | 37 | 2008 |
